Psychiatric Drug Facts via breggin.com :

“Most psychiatric drugs can cause withdrawal reactions, sometimes including life-threatening emotional and physical withdrawal problems… Withdrawal from psychiatric drugs should be done carefully under experienced clinical supervision.” Dr. Peter Breggin
Showing posts with label CSTC. Show all posts
Showing posts with label CSTC. Show all posts

Sep 25, 2012

Thank You For The Ominous Long-Term Health Risks

Quack Master Jack McClellan

"Whenever a doctor cannot do good, he must be kept from doing harm."  Hippocrates

Jon McClellan, the lead researcher for childhood schizophrenia in Washington State, is a doctor who should be stopped.  He is the psychiatrist who gave my son neuroleptic and other  psychotropic drugs without consent. He repeatedly told me I had no say in treatment decisions; no say about what drugs he gave my son.  He drugged my son without consent, much less, Informed Consent; while trialing neuroleptic drugs for FDA approval; so the drugs he used were not approved for use on children.  Drugged my son over my objections, into a state of profound disability. He told me I had no say in what drugs were given to my boy, who had an IQ of 146.  It is frightening that this man is still the Medical Director of the State-run psychiatric facility for children.

Schizophrenia is a diagnosis of exclusion.  What that means is that any and all other explanations for the symptoms must be excluded.  Until this researcher got a hold of him, my son was diagnosed with Temporal Lobe Epilepsy and PTSD, the latter due to having been severely traumatized, in foster care.  Both of these can cause the symptoms which Dr. McClellan concluded were symptoms of schizophrenia.  When I asked him if he was going to do an EEG to rule out the Temporal Lobe Epilepsy; he said it was not necessary.  My protests were labeled denial, my input was dismissed; I was told I had no say.

Ultimately, McClellan put my son on Clozapine which between 1998 and 2005 was linked to 3,277 deaths in the U.S. and over 4,300 events that resulted in disability or required medical intervention, according to the data in the FDA Medwatch adverse events reporting system.  Dr. McClellan lied to me and said that since the drugs was  put back on market in the US, with mandatory blood draws, no one had died from it's use. He also told me that it was only over in Europe that anyone died at all.  This conversation happened only after he had put my son on the drug, as did all the conversations about what drugs he was using to treat my son. Like all of the drugs used by Jon McClellan, on my son, it was not approved for pediatric use for the reason McClellan prescribed them.

The reality is, no matter the diagnosis or the symptoms; this doctor had no right to use my son as a guinea pig---and he had no legal authority to drug him without my consent.  He did not have my son's consent---or his mother's permission; he did not comply with the Hippocratic oath, the ethics guidelines of the medical profession, the laws of the State of Washington, Federal Medicaid guidelines, the U.S. Constitution, or the Nuremberg Code.  There is no way in hell I would have given consent, had I been given the opportunity and actually been informed, which he did not think was necessary. Quack Master Jack, Jon McClellan, a "lead researcher" funded by NIMH, played God.

What is known and has been know about this class of drugs for decades, is that they cause iatrogenic, i.e. physician caused; diseases, neurological impairments, disability, and sudden, and early death.  These are know risks, and as such, should be information discussed prior to administration.  I found these facts out on my own, not in any conversation I had with "Dr. Jack," as he told the kids to call him.  My son, who still takes Clozapine, is unaware of these risks; no psychiatrist has discussed them with him.  McClellan used many anti-psychotics, on my son without adhering to any ethical, moral, or legal standard; knowing this, I am disgusted that this man never loses an opportunity to decry their over-use.  He had no problem using them to drug my son; without warning either my son or myself about the "Ominous Long-Term Health Risks."

It didn't matter to Quack Master Jack that he didn't have 
Informed Consent from the patient or his MadMother.
I was never asked if I wanted to sacrifice my son on the altar of corporate greed and have my son used in Drug Trials. Had I been asked, there's no way in hell I would have given consent. The TEOSS Drug Trial was a "seeding trial," the purpose of a "seeding trial" is gain FDA approval for a drug to treat a new condition, or a different population; to expand the drug market and ensure that BigPharma continues to make a killing
figuratively and literally...
It matters to this MadMother.
Does it matter to you?

Link to The Belmont Report and Nuremberg Code:


Originally published on December 17, 2010

Mar 16, 2012

mental illness is like any other illness? not in my family's American experience

I have wondered for years, why are reports and data from research paid for with Government Grants, is not readily accessible to the American people,  Is it because it is more difficult to defraud people when you put the actual information in front of them; not just the biased press releases and public service announcements developed by marketing departments?  Journalists, at one time used to independently verify information before "going with the story;" reporting the news.  There are studies conducted paid for by NIMH, and not published in this country.  How often is this happening?  It is not unusual, I have found.  In effect, the American people pay for research, and do not have ready access to the results.

Most of the research that is published here in the US is published in 'peer-reviewed' professional journals that restrict access.  Yet, we are expected to accept that the research was done correctly and ethically, our acceptance is to be based solely on a report, not the data itself. (reports can be biased and offered by someone with a Conflict of Interest)   Propaganda passes for news and press releases from marketing departments for 'news in the public interest.'  Major media news outlets use these press releases as 'news.' News can be reported along with a heavy dose of direct-to-consumer advertising for a product that is in the news. Biased reporting of medical studies being presented alongside copious direct to consumer marketing results in a seriously misinformed populace. Seems to me, it would increase the risk for harm.

It is a free country and any one who chooses to take the willfully blind and/or ignorant route is free to do so.  I am not one of them, and I am so totally outraged by how my family has been treated by people who are public servants and public employees, theoretically, working for us, but acting against us illegally at times, actually committing Federal Crimes, violating our civil rights.  Some public servants have committed perjury in Courts of Law, and retired with pensions.  These crimes were reported; and covered up,instead of being investigated or prosecuted.   I have been slandered and maligned by some of these people; so has my son.  In vain, I have desperately sought Justice for my youngest son; fought for my Constitutional Rights as a parent, and for my son's Human Rights as a trauma victim since 1993.  I have been treated with disrespect by public servants who have abused their authority and power people who have committed the felony crimes of perjury, forgery, Medicaid fraud. The worst of all, were those who medically neglected, tortured and physically abused my traumatized son, with impunity.  These events traumatized all of us--and disabled my brilliant son.

Jon McClellan, psychiatrist, "Quack Master Jack,"  i.e. the thug in a white coat who drugged my kid into a state of disability without Consent (Informed or otherwise).  He repeatedly told me I had NO SAY.  Quack Master Jack gets 1.8 million dollars bi-annually from the State of Washington.  I asked my State Senator and both State Representatives, to help me.  I have been given the silent treatment.  Good ol' boys, that I actually voted for.  I asked them to look into this knowing it is germane, I know that my concerns are valid.  The State of Washington's foster children, kids in treatment, in group homes and correctional facilities are not protected from the risks of the kind of iatrogenic harm that disabled my son.

Is it not a priority to protect children who are in the State's custody?

One of them the two representatives actually asked what I wanted him to do?!  I suggested he represent his constituents, namely my son, and myself.  I then suggested perhaps maybe the kids in state custody, even though they don't vote yet; are in need of his representation.  There are 47 children in Child Study and Treatment Center, consistently, at least 50 %, if not more are in fact Wards of the Court. Kids who do not have families involved to offer support, or Informed Consent.

My son spent more than 5 out of 10 years of his childhood in this facility.    He was "traumatized over and over and over;" it was none too easy on his brother and myself, I assure you.  He asked me in agony, "how could they take so much from me mom?"  I have no answer.  I know I will remember the sound of my child's terror-filled pleas echo in my memory for the rest of my life.  I know I tried to stop that prick.  I know I can not do anything to change what happened.  I know I have a duty to do whatever is in my power to stop it from happening to anybody else.

Kids who don't yet know that they have Constitutional Rights and that if these Rights are not defended, there is no equal protection under the law.  I bet a lot of those kids know they are not "protected."  I can't forget.

In Washington State, adolescents at the age of thirteen have the legal right to give consent for mental health services and substance abuse treatment.  Parental permission or consent is not required.  This law was passed to enable kids who have a desire to get help, who do not have their parent's support to get the help they need.  This law is in fact being used to exclude parents---in effect, denying parental rights to make medical decisions,  for their children.  This is happening in families who are not involved in "the system."   Reading the law it is clear to me that while it gives minors the right to consent to treatment--it does not diminish, or imply that a parent's Constitutional Rights are as a result diminished.

What is happening in real life is professionals are telling kids, "your parents do not need to be involved at all--we don't need them here.  You are old enough to make these choices for yourself."  In reality, an intelligent mature adult would have difficulty; since in order to provide Informed Consent, one needs to be given accurate unbiased information, and make a decision without being coerced.  Unless it is an emergency, a person is to have an opportunity to consult with others before receiving the prescribed "treatment" (drug or drugs)  Much of what is known about the drugs used for emotional and behavioral symptoms is based on a tainted and biased evidence base.  Rampant fraud and corruption in the FDA approval process and in the marketing of psychiatric drugs, puts everyone at risk.  It is obvious this law places children at risk. How many thirteen to eighteen year olds would know what kind of questions to ask about possible risks, potential benefits, and ask if there is anything besides drugs to help them? (that won't possibly cause dangerous negative effects, possibly disable them and/or cause their untimely death?) 


In the FDA AERs database, #574579 is Rebecca Riley, there is another 4 year old's death listed in 2007 from Seroquel--no gender is  listed and that is more that a little sad. A child who is reduced to a nameless, faceless statistic...I wonder did anyone cry over that child's death besides me?

How many kids (or parents) are actually told of the risk of fatality or heart damage from the drugs used to "treat" ADHD?  Are they told the drugs are in fact addictive, and that some have the same effect on the brain as illicit drugs?  Antipsychotics are being used for behavior control, for "bipolar" the most recent diagnosis de jour.  They are addictive, potentially disabling, and/or fatal; used as directed---even when the drugs appear to be 'helping' and are perceived as beneficial by the person taking them, used long term can cause serious iatrogenic diseases and brain damage.  I know this NOT because any psychiatrist or other mental health professional ever told me, but, because I made it my business to start researching when Quack Master Jack's behavior caused me to mistrust him.

Deceptive practices allow psychiatry and pharma to continue to do a smoke and mirrors snake oil medicine show with our psyches, our tax dollars, our Police, our Courts, AND our fundamental freedoms; our Human Rights.  Fraud, corruption and Human Rights crimes committed against individuals who are given a diagnosis. When diagnoses are adjudicated in Courts of Law, court procedures do not adhere to the same standards appplicable in any other court proceeding.  Civil Commitment laws virtually eviscerate the Rules of Evidence standard. The reason this is done is because diagnostic criteria and treatment standards rely on subjective opinions and are Standardized for clinical use by a quasi-democratic process. It is impossible to submit evidence in compliance with the Rules of Evidence that any psychiatric diagnosis is caused by a disease---such an attestation could not be supported with scientific evidence in compliance with the Rules of Evidence.

The treatment can be disabling or lethal...no biggie...at all.
NAMI says 'mental illness is like any other illness' 

A teacher in grade-school taught me about the Constitution of the United States of America. This document is gospel.  It is The American Gospel; it is why people seek refuge, and their own American dream here more than two hundred years after The Constitution was written.  I wonder... when I am once again struck by the injustice, the utter disregard for the law, and the manner in which our individual rights were neither preserved, nor defended; I (still) wonder, if I am naive?

I do not believe so.  I am grievously disappointed in my fellow man, and in My Country.  My sons and I are not victims; we are survivors.  The Constitution of the United States of America is Our American Gospel.  We know there just aren't enough people who understand exactly what is at stake.  We have elected representatives, and paid public servants who swear solemn oaths, yet fail to fufill their sworn duties.

It is a failure that has altered the course of my family's American experience.


"Whenever a doctor cannot do good, he must be kept from doing harm." 
Hippocrates


“Justice without force is powerless; force without justice is tyrannical.”  

Blaise Pascal

"Watch out for people who begin with another's concern to end with their own." 
Balthasar Gracian


"God grant me the courage not to give up what I think is right 
even though I think it is hopeless."
Chester W. Nimitz



The bible verse associated with my name

My Dad's Army Air Corps Unit's Motto
"Sustineo Alas" translation: "I sustain the wings"  



portions of this were first posted February 2011

Feb 28, 2012

AACAP Practice Parameters recommend using neuroleptic and other psychotropic drugs 'off-label'

Jon McClellan

It is Standard Practice to prescribe neuroleptic, called "antipsychotic," and other psychiatric drugs which have not been approved for pediatric use, that is, not tested for safety and/or efficacy in children and adolescents. The reason it is a standard practice is because Treatment Protocols and Practice Parameters and treatment algorithms written by Jon McClellan and other child and adolescent psychiatrists recommend prescribing the teratogenic drugs for children's behavioral problems, and for virtually every psychiatric diagnosis given to children and teens---there have even been reports the drugs are prescribed absent any psychiatric diagnosis...


What really gets me about this 'doctor' is considered a lead researcher, 'an authority' who actually wrote the book, so to speak, on prescribing teratogenic drugs to kids, yet he claimed in a Senate Hearing under oath that he had no insight into why it has become a "Standard Practice!"  Jon McClellan's failure to comply with or conform to Ethical Guidelines and Legal Standards when he 'treated' my son, should have cost him his license to practice medicine.  This 'doctor,' as an agent working for the State of Washington, violated every single Ethical and Legal parameter applicable to the practice of medicine and bio-medical research involving human subjects, he used my son like a lab animal without regard to his human dignity; without obtaining the proper consent, and over my vehement protests.  This 'doctor' claimed in a Senate Hearing to have no insight into how the teratogenic drugs he recommends in his professional writing and that he advises other professionals how to prescribe off-label, came to be widely prescribed to children and adolescents without the empirical data necessary to or support prescribing the drugs as a medical treatment at all, 


Jon McClellan's callous disregard for the deleterious effects of the drugs on my son was horrifying for a mother to witness; his utter lack empathy and compassion were devastating, as was the lack of accountability or responsibility for further traumatizing and ultimately disabling my once brilliant son.

Jon McClellan has ample experience prescribing psychotropic drugs off-label over the last couple of decades.  He has taught students at the University of Washington, and advises other medical professionals in phone consultations in a program that Washington State implemented.  In spite of these facts, and a professional career over 2 + decades, he claims to have no insight whatsoever into the prescribing practices he uses and recommends to others.  Prescribing practices which have defrauded taxpayers through the Medicaid program.  Worse than the decimated budgets and robbing of the American taxpayers, is the plight of the primary victims of this psychiatric practice: the children whose lives have been forever altered, like my son's has been; and the children whose lives have been lost: like Rebecca Riley and Gabriel Meyers.  


Does anyone really believe Jon McClellan has absolutely no insight into the reason this investigation is needed? Does anybody wonder what happens to doctors who prescribe drugs off-label, and ultimately cause a child's death? The doctor that "treated" Gabriel Meyer to death, got a "warning letter" and still has a medical license to practice medicine.  The doctor that "treated" Rebecca Riley to death was granted immunity for testifying against her mother at trial. As usual, Jon McClellan was quoted in the press when these events occurred:  This expert who claims he has NO IDEA why these drugs are being used so widely, with such ill effects, without being first tested or approved as safe and/or effective for pediatric use, always has something to say when the off label use of teratogenic drugs result in a child's death. He testified in a Senate hearing that he has NO IDEA why the drugs he himself recommends using off label and concomitantly in treatment guidelines and practice parameters, are being used in off label and concomitantly...
More importantly, what are the recommendations based on?  


via ACCAP:
PRACTICE PARAMETER FOR THE ASSESSMENT AND TREATMENT OF 
CHILDREN AND ADOLESCENTS WITH SCHIZOPHRENIA
This parameter was developed by Jon McClellan, M.D., and John Werry, M.D. here and here



PRACTICE PARAMETER FOR THE USE OF ATYPICAL ANTIPSYCHOTIC 
MEDICATIONS IN CHILDREN AND ADOLESCENTS
This parameter was reviewed at the Member Forum at the AACAP Annual Meeting in 
October 2006.
From January 2008 to October 2008 and from November 2010 to June 2011, this 
parameter was reviewed by a Consensus Group convened by the CQI. Consensus Group 
members and their constituent groups were as follows: CQI (Oscar Bukstein, M.D., chair and 
shepherd; Allan Chrisman, M.D., John Hamilton, M.D., and Matthew Siegel, M.D., members); 
Topic Experts (Jon McClellan, M.D. and Christopher McDougle, M.D.); AACAP Assembly of 
Regional Organizations (Sherry Barron-Seabrook, M.D. and Gail Edelsohn, M.D.); and AACAP 
Council (David R. DeMaso, M.D. and Melvin Oatis, M.D.).   
This practice parameter was approved by the AACAP Council on August 2, 2011 here

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder
Accepted August 15, 2006.
This parameter was developed by Jon McClellan, M.D., Robert Kowatch, M.D.,
Robert L. Findling, M.D., 
This parameter was reviewed at the member forum in October 2004 at the
annual meeting of the American Academy of Child and Adolescent Psychiatry.
During August 2005, a consensus group reviewed and finalized the content of
this practice parameter. The consensus group consisted of representatives of relevant
AACAP components as well as independent experts: Oscar Bukstein, M.D., Work
Group Co-Chair; Jon McClellan, M.D., author here

Summary of the Practice Parameters for the Assessment and Treatment of Children and Adolescents with Depressive Disorders


Principal Authors: Boris Birmaher, M.D., David A. Brent, M.D., and R. Scott Benson, M.D. This Summary was developed by the Work Group on Quality Issues: William Bernet, M.D., Chair, and John E. Dunne, M.D., former Chair, Maureen Adair, M.D., Valerie Arnold, M.D., R. Scott Benson, M.D., Oscar Bukstein, M.D., Joan Kinlan, M.D., Jon McClellan, M.D., and David Rue, M.D. here






Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults


via Alliance for Human Research Protection

Evidence of Neuroleptic Drug-Induced Brain Damage in Patients:
A partial, Annotated Bibliography
by Vera Hassner Sharav

For distribution: January, 2000

(links disabled)
Although patients, families and the public were not informed - some would argue they were deceived - clinical psychiatrists and researchers have long known about severe adverse drug reactions (ADR) and disabling changes in the central nervous system in a high percentage of patients taking standard neuroleptic drugs. Foremost among these is "tardive dyskinesia" (TD), an often irreversible, disfiguring disorder of the central nervous system resulting in a variety of involuntary movements, particularly of the tongue, lips, and jaw. muscle movements which affects 40% to 60% of patients taking neuroleptics. Recent research findings corroborate earlier reports (since 1970) linking TD to a deterioration of cognitive functions (see below).
Other severe ADRs include: "extrapyramidal symptoms" (EPS), Parkinson-like, impaired motor coordination; sedation; extreme restlessness ("akathesia"); reduced cognitive function;as well as cardiovascular effects, orthostatic hypotension, abnormal liver changes, anticholinergic side effects, sexual dysfunction, and weight gain. Psychotic relapse has been linked to long-term neuroleptic treatment --referred to as, "supersensitivity psychosis." Additionally, there is a one percent risk of "neuroleptic malignant syndrome" (NMS), a potentially fatal side effect. These, and a host of other adverse side effects, cause most schizophrenia patients to stop taking these drugs.
In an article written in 1986, Tardive Dyskinesia: Barriers to the Professional Recognition of Iatrogenic Disease, [Journal of Health and Social Behavior,1986, 27: 116-132], Brown and Funk stated: "tardive dyskinesia (TD), once regarded by psychiatrists as a rare syndrome, is currently recognized as the second most pervasive side effect following sedation of antipsychotic drugs." Although evidence linking TD to neuroleptic drugs had been shown since 1957, Brown and Funk point out that the recognition of TD as a side effect had been "a slow and uneven process, involving psychiatric resistance....Even when physicians believe that patients should be informed about the risks of TD, usually only incomplete information is given, not all patients at risk are informed...." And, they noted, "psychiatrists who are critical of the profession's lax treatment of the problem argue that if doctors were really concerned, they would reduce their use of neuroleptics and reduce dosages when drugs are employed..." and they would fully disclose the risks of TD to their patients.
But a review of the history of TD demonstrates clearly that despite the evidence physicians' disclosure and practice with respect to neuroleptic drugs has remained unchanged, and TD afflicts ever more patients, especially after long-term exposure-estimates range between 40% to 60%. The APA has opposed written informed consent from patients.
Van Putten T, Marder SR (1987) Behavioral toxicity of antipsychotic drugs. J Clin Psychiatry 1987 Sep;48 Suppl:13-9
Extrapyramidal symptoms cause much misery, often go undiagnosed, and can interfere with treatment and rehabilitation. Akinesia is a behavioral state of diminished motoric and psychic spontaneity that is difficult to distinguish from the negative symptoms of schizophrenia. The most useful clinical correlates of akinesia are a subjective sense of sedation and excessive sleeping. Akinesia interferes with social adjustment and may manifest as "postpsychotic depression." The subjective restlessness of akathisia is usually accompanied by telltale foot movements: rocking from foot to foot while standing or walking on the spot. Akathisia is strongly associated with depression and dysphoric responses to neuroleptics and has even been linked to suicidal and homicidal behavior in extreme cases.

Recent Findings Corroborate high incidence of drug-induced movement disorders:

Miller LG, Jankovic J (1990) Neurologic approach to drug-induced movement disorders: a study of 125 patients.South Med J 1990 May;83(5):525-32. Department of Family Medicine, Baylor College of Medicine, Houston, Tex.
Of 125 patients with neuroleptic (dopamine blocking) drug-induced movement disorders who had been referred to a specialized clinic to differentiate the predominant movement disorder, 63% had tardive dyskinesia, 30% had parkinsonism, 24% had dystonia, 7% had akathisia, and 2% had isolated tremor. Two or more movement disorders coexisted in 31 patients (25%).
Functional disability was more severe in patients with akathisia than in other patients. Women outnumbered men at a ratio of 4:1, except for tardive dystonia which affected both sexes equally. The average at onset was 56 years (range, 13 to 87); 69 patients (55%) had onset of movement disorder in the sixth decade. While tardive dystonia was distributed relatively evenly in all age groups, almost a third of patients with parkinsonism had it in the eighth decade. Haloperidol was implicated in 47 patients (37%), followed by amitriptyline/perphenazine in 30%, thioridazine in 27%, and chlorpromazine in 20%. Metoclopramide-induced movement disorders were found in 10 (8%). Most patients (101 or 81%) had history of psychiatric illnesses, but of these only 44 had psychosis.
Neuroleptic drugs had been prescribed for 33 patients (26%) who had gastrointestinal problems. It is important to recognize and differentiate various drug-induced movement disorders because such differentiation has pathophysiologic and therapeutic implications. Many patients could have been treated with less potent drugs.
Muscettola G, Barbato G, Pampallona S, Casiello M, Bollini P (1999) Extrapyramidal syndromes in neuroleptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia. J Clin Psychopharmacol 1999 Jun;19(3):203-8
ABSTRACT: Prevalence and risk factors for extrapyramidal syndromes (EPS) were investigated in a sample of 1,559 patients. The overall prevalence of EPS was 29.4% (N = 458). Among the EPS-diagnosed patients, Parkinsonism as assessed by the presence of core Parkinsonian symptoms (rigidity, tremor, bradykinesia) was present in 65.9% of patients (N = 302), akathisia in 31.8% (N = 145), and acute dystonia in 2.1% (N = 10).
EPS was diagnosed in 50.2% of 285 patients with persistent tardive dyskinesia (TD). Distribution of EPS in patients with TD showed that tremor and akathisia were more frequent in peripheral TD cases than in orofacial TD cases. Furthermore, there was a stronger association of NL-induced parkinsonism with peripheral TD than with orofacial TD. This study suggests that the association between EPS and TD may be limited to specific subtypes of TD. Peripheral TD showed a higher association with parkinsonism and with akathisia, suggesting that these symptoms may share a common pathophysiology.

Bristow MF, Hirsch SR (1993) Pitfalls and problems of the long term use of neuroleptic drugs in schizophrenia. Drug Safety 1993 Feb;8(2):136-48. Academic Department of Psychiatry, Charing Cross and Westminster Medical School, London, England.
ABSTRACT: Although acute and immediate extrapyramidal syndromes are common and, in the case of neuroleptic malignant syndrome, may have serious sequelae, the most important problem with psychotropic medication in schizophrenia remains the tardive movement disorders. These are increasingly recognised as being aetiologically as well as symptomatically heterogeneous. Although risk factors are being identified with greater clarity, there is little in the way of effective treatment. This suggests that clinicians must embark on long term neuroleptic treatment with vigilance. Clozapine alone has few extrapyramidal effects, and has been described in isolated instances as improving established movement disorders. However, haematological idiosyncrasies will preclude its use in all where compliance is uncertain. Its superior efficacy will hopefully give impetus to research into safer analogues.
Hansen TE, Brown WL, Weigel RM, Casey DE (1992) Underrecognition of tardive dyskinesia and drug-induced parkinsonism by psychiatric residents. Gen Hosp Psychiatry 1992 Sept; 14(5):340-4. Portland Veterans Affairs Medical Center, Oregon Health Sciences University 97207.
Recognition of tardive dyskinesia (TD) and other neuroleptic, drug-induced, extrapyramidal side effects presents a major challenge in modern clinical psychopharmacology. Failure to recognize these disorders can lead to poor patient care and may contribute to societal pressure for external control of psychiatric practice. This study reports the occurrence of tardive dyskinesia and drug-induced parkinsonism (DIP) in 101 inpatients, and documents under recognition of both disorders by resident physicians.
Researchers noted TD in 28% of cases and residents only described TD (or symptoms ofTD) in 12%. The researcher determined DIP prevalence rate of 26% contrasted with an 11% rate found by residents. Patients with psychotic disorders were more likely than other patients to have researcher-identified TD, whereas DIP (researcher cases) occurred more often in patients with affective diagnoses. Residents tended to miss milder cases of TD, and to miss DIP in younger patients and in patients with affective disorders. Improved teaching and clinical exams are recommended to improve recognition.

Neuroleptic drug induced psychotic relapse ("supersensitivity psychosis")

Chouinard G. Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment. Schizophr Res 1991 Jul-Aug;5(1):21-33 Psychiatric Research Center, Louis-H. Lafontaine Hospital, University of Montreal, Quebec, Canada.
ABSTRACT: Tardive dyskinesia is thought to result from neostriatal dopaminergic receptor supersensitivity induced by chronic treatment with neuroleptics. Similarly, receptor supersensitivity occurring in other dopaminergic regions of the brain could result in the development of supersensitivity psychosis. As with tardive dyskinesia, severe forms of the disorder are rare. Ten such cases are described whose main characteristic is that psychotic symptoms can no longer be masked by increased dosages of neuroleptics. Diagnostic criteria for the disorder are proposed, and treatment with antiepileptic medication is described.
Kirkpatrick B, Alphs L, Buchanan RW (1992) The concept of supersensitivity psychosis. J Nerv Ment Dis 1992 Apr;180(4):265-70. Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore 21228.
ABSTRACT: The hypothesis that chronic neuroleptic treatment may induce relapse in some schizophrenic patients has received considerable attention. This effect, usually called supersensitivity psychosis, has been attributed to neuroleptic-induced changes in mesolimbic or mesocortical dopaminergic receptors. However, research has not established that neuroleptics cause the proposed effect, and considerations of mechanism have not been separated from those of causation. The focus of research in this area should be the establishment or refutation of a causal relationship between chronic neuroleptic use and psychotic relapse.
Chouinard G, Sultan S. Treatment of supersensitivity psychosis withantiepileptic drugs: report of a series of 43 cases. Psychopharmacol Bull 1990;26(3):337-41. Allan Memorial Institute, Montreal, Quebec, Canada.
Supersensitivity psychosis has emerged as a potential side effect of long-term neuroleptic therapy that may be similar to tardive dyskinesia. Schizophrenic patients with supersensitivity psychosis and considered to be drug-resistant were treated with anti-epileptic medication. Forty-three separate trials were conducted on a total of 35 patients. Over half improved on clinical global impression, some of them considerably. We propose that antiepileptic drugs ameliorate supersensitivity psychosis and so-called "drug-resistant" schizophrenic patients by correcting a pharmacological kindling effect in the limbic system which results from chronic neuroleptic therapy. Publication Types: Clinical trial
Kahne GJ. Rebound psychoses following the discontinuation of a high potency neuroleptic. Can J Psychiatry 1989 Apr;34(3):227-9
Increased familiarity with the effects of psychotropic medications has led to modifications in both prescribing habits and length of treatment. The case of a 34 year old woman is presented, in whom the return of psychotic symptoms following the discontinuation of neuroleptic medications is attributed to a rebound phenomena as opposed to a relapse of an underlying chronic illness
The author cites parallel situations previously described in the medical literature and outlines a conceptual framework for the understanding of this phenomenon.
Bowers MB Jr, Swigar ME. Psychotic patients who become worse on neuroleptics. J Clin Psychopharmacol 1988 Dec;8(6):417-21. Yale University School of Medicine, Department of Psychiatry, New Haven, Connecticut
ABSTRACT: We describe a group of psychotic patients who became worse early in the course of neuroleptic treatment. Characteristics of this group were: predominantly female sex, relatively brief onset, family history of affective disorder, hypomotoric presentation, and severe neuroleptic side effects. We propose that some patients with affective psychoses are uniquely susceptible to profound blockade of the nigrostriatal dopaminergic system by neuroleptics.

During the 1990s, the "Decade of the Brain:"

Newer "atypical" neuroleptics have been developed-clozapine, risperdone, olanzapine and quitepane-these drugs have a lower risk of EPS and TD, but are associated in varying degrees with sedation, cardiovascular and liver enzyme abnormalities, anticholinergic effects, extreme weight gain (30lbs to 50lbs) which significantly increases the risk for diabetes, sexual dysfunction, NMS, seizures, mania, and (in the case of clozapine) agranulocytosis.
Additionally, mounting clinical evidence and findings -from non-industry sponsored research-point to additional, severe, adverse neurological changes in response to long-term exposure to neuroleptics. These drugs' actions suppress certain brain receptors (e.g., dopamine, glutamate), and when such drugs are withdrawn (or a patient stops taking them) the drug-induced receptor changes are unmasked, causing an acute "discontinuation syndrome" (i.e., "rebound psychosis" ) that is often more severe than the original symptoms of the illness. Psychotic relapse can cause months of mental and emotional anguish and loss of functioning-rebound psychosis can cause violent and suicidal behavior in patients not previously violent. [Often, these drug-induced reactions are used to justify forcing the person back on the drugs.]
Collaborative Working Group on Clinical Trial Evaluations. Adverse effects of the atypical antipsychotics. J Clin Psychiatry 1998; 59 Suppl 12:17-22
ABSTRACT: Adverse effects of antipsychotics often lead to noncompliance. Thus, clinicians should address patients' concerns about adverse effects and attempt to choose medications that will improve their patients' quality of life as well as overall health. The side effect profiles of the atypical antipsychotics are more advantageous than those of the conventional neuroleptics. Conventional agents are associated with unwanted central nervous system effects, including extrapyramidal symptoms (EPS), tardive dyskinesia, sedation, and possible impairment of some cognitive measures, as well as cardiac effects, orthostatic hypotension, hepatic changes, anticholinergic side effects, sexual dysfunction, and weight gain.
The newer atypical agents have a lower risk of EPS, but are associated in varying degrees with sedation, cardiovascular effects, anticholinergic effects, weight gain, sexual dysfunction, hepatic effects, lowered seizure threshold (primarily clozapine), and agranulocytosis (clozapine only). Since the incidence and severity of specific adverse effects differ among the various atypicals, the clinician should carefully consider which side effects are most likely to lead to the individual's dissatisfaction and noncompliance before choosing an antipsychotic for a particular patient.
Wyderski RJ, Starrett WG, Abou-Saif A. Fatal status epilepticus associated with olanzapine therapy. Ann Pharmacother 1999 Jul-Aug;33(7-8):787-9. Department of Internal Medicine, School of Medicine, Wright State University, Dayton, OH 45409, USA. rjwyderski@mvh.org
OBJECTIVE: To report a case of fatal status epilepticus in a patient using olanzapine with no known underlying cause or predisposing factor for seizure. CASE SUMMARY: A 41-year-old white woman developed witnessed seizures at home that progressed to status epilepticus. She subsequently died from secondary rhabdomyolysis and disseminated intravascular coagulation.She had been taking olanzapine for five months prior to the event. No other toxic, metabolic, or anatomic abnormalities were identified pre- or postmortem to explain the seizures. Her seizures were a probable adverse drug reaction based on the Naranjo scale.
DISCUSSION: This is the first case of fatal status epilepticus described that has been associated with the use of olanzapine. The pharmacodynamics of olanzapine are similar to those of clozapine, which has been described to induce seizures in 1-4% of patients. It is possible that this patient may have suffered seizures due to a similar effect. Alternate explanations include neuroleptic malignant syndrome and alcohol or benzodiazepine withdrawal seizures, although her clinical history does not suggest these etiologies.
CONCLUSIONS: Although olanzapine has infrequently been associated with seizures in premarketing studies, its potential to induce them exists. Postmarketing surveillance should continue to determine how significant this effect may be.

Drug induced "rebound psychosis" & Mania

Shore D. Clinical implications of clozapine discontinuation: report of an NIMH workshop. Schizophr Bull 1995;21(2):333-8. Division of Clinical and Treatment Research, NIMH, Rockville, MD 20857, USA.
ABSTRACT: In September 1994, the National Institute of Mental Health convened a group of scientists to discuss the clinical effects of rapid clozapine discontinuation, especially in light of the introduction of risperidone for the treatment of schizophrenia. Despite concern over recent reports of clinical deterioration (psychotic exacerbations, somatic withdrawal symptoms, and extrapyramidal side effects) in a few patients abruptly discontinued from clozapine, there is currently insufficient information to determine the magnitude of the problems associated with clozapine withdrawal.
However, clinicians are reminded that the withdrawal schedule for clozapine indicates a gradual tapering schedule (unless the patient is experiencing severe side effects); that switching patients from clozapine to risperidone does not mean that such tapering is unnecessary; and that the use of risperidone may not produce all of the same effects as clozapine in some treatment-refractory patients. PMID: 7543218, UI: 95357664
Stanilla JK, de Leon J, Simpson GM. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases. J Clin Psychiatry 1997 Jun;58(6):252-5. Department of Psychiatry, Allegheny University, Norristown State Hospital, Pa. 19401, USA.
BACKGROUND: Withdrawal symptoms for typical antipsychotics are generally mild, self-limited and do not include development of psychotic symptoms. In contrast, withdrawal symptoms for clozapine can be severe with rapid onset of agitation, abnormal movements, and psychotic symptoms. Different pathophysiologic etiologies have been suggested for these severe symptoms, including dopaminergic supersensitivity and rebound. METHOD: Three case reports of clozapine withdrawal symptoms are presented. A review of previous case reports and discussion of the etiology of withdrawal symptoms of typical antipsychotics and clozapine are provided.
RESULTS: These three patients developed delirium with psychotic symptoms that resolved rapidly and completely upon resumption of low doses of clozapine.
CONCLUSION: The severe agitation and psychotic symptoms after clozapine withdrawal in these three patients were due to delirium, perhaps the result of central cholinergic rebound. The withdrawal symptoms and delirium resolved rapidly with resumption of low doses of clozapine. Severe withdrawal symptoms can probably be avoided by slowly tapering clozapine and/or simultaneously substituting another psychotropic with high anticholinergic activity, such as thioridazine.
Durst R, Teitelbaum A, Katz G, Knobler HY (1999) Withdrawal from clozapine: the "rebound phenomenon". Isr J Psychiatry Relat Sci 1999;36(2):122-8. Jerusalem Mental Health Center, Kfar Shaul Hospital, Israel.
Clozapine is an "atypical" antipsychotic agent for treating previously resistant schizophrenic patients. Its main advantages over "typical" neuroleptics are low incidence of extrapyramidal side effects and its capacity to induce therapeutic response in previously treated refractory patients. However, withdrawal from clozapine has been observed to lead to "atypical" clinical characteristics or a "rebound phenomenon," manifested in two interwoven clinical forms: (1) psychotic exacerbation, and (2) cholinergic rebound. The underlying pathophysiological mechanism of this phenomenon is postulated to be a result of cholinergic supersensitivity. In this paper, the "rebound phenomenon" will be discussed and exemplified by three case histories in which abrupt cessation of clozapine led to serious deterioration and psychotic exacerbation, and one case in which gradual titration from the drug was employed in order to preempt this hazardous occurrence. PMID: 10472746, UI: 99401971
Still DJ, Dorson PG, Crismon ML, Pousson C Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone. Psychiatr Serv 1996 Dec;47(12):1382-4. Department of Psychiatry, Community Hospitals Indianapolis, IN 46219, USA.
A prospective, open-label study in a 400-bed state psychiatric hospital evaluated change in therapeutic response among ten patients with treatment-resistant schizophrenia who were switched from clozapine to risperidone. Drug effects were examined before discontinuation of clozapine and at three, six, nine, and 12 weeks of risperidone treatment. No patients improved, and five discontinued treatment due to exacerbation of psychosis or adverse effects. Changes in scores on the Positive and Negative Syndrome Scale, the Brief Psychiatric Rating Scale, and the Barnes Akathisia Scale indicated clinically significant worsening of symptoms. The findings do not support replacing clozapine with risperidone for patients with treatment-resistant schizophrenia.
Delassus-Guenault N, Jegouzo A, Odou P, Seguret T, Zangerlin H, Vignole E, Robert H. Clozapine-olanzapine: a potentially dangerous switch. A report of two cases. J Clin Pharm Ther 1999 Jun;24(3):191-5. Department of Pharmacy, EPSM Lille-Metropole, Armentieres, France.
BACKGROUND: Withdrawal symptoms associated with switch between two typical antipsychotics are generally rare and mild. In contrast, switching from clozapine to risperidone can be lead to severe withdrawal symptoms. Different pathophysiologic aetiologies have been suggested for explaining these severe symptoms, including cholinergic supersensitivity and rebound. Theoretically, the switch from clozapine to olanzapine should not lead to any problems because those two agents have the same affinity in vitro for muscarinic receptors. OBJECTIVE: This study reports two cases of switches from clozapine to olanzapine, in refractory schizophrenic patients, which were associated with severe withdrawal symptoms.
RESULTS: After the switch, the two patients developed diaphoresis, hypersialorrhea, bronchial obstruction, agitation, anxiety and enuresis. The symptoms were treated with anticholinergic medication and by an increase in dose of olanzapine to 20 mg/day. For one of the patients this treatment led to normalization of secretion. For the other patient, a superinfection leading to a bilateral pneumopathy which required emergency hospitalization in a general hospital was observed.
CONCLUSION: The symptomatology and the response to treatment lead to the hypothesis of a muscarinic from abrupt weaning. The withdrawal symptoms disappeared rapidly with an increase in olanzapine dosage and with anticholinergic started at the beginning of the switch. We recommend slow clozapine weaning over 3 weeks or more with concurrent anticholinergic treatment.
Ekblom B, Eriksson K, Lindstrom LH. Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology (Berl) 1984;83(3):293-4.
In two patients with chronic schizophrenia, who were on clozapine medication for more than 6 months, a sudden withdrawal of the drug resulted in a very pronounced deterioration of the psychosis within 24-48 h. The most prominent symptoms were auditory hallucinations and persecutory ideas and one patient tried to commit suicide. These observations are interpreted as supersensitivity psychoses induced by the very effective clozapine treatment.
Jauss M, Schroder J, Pantel J, Bachmann S, Gerdsen I, Mundt C. Severe akathisia during olanzapine treatment of acute schizophrenia. Pharmacopsychiatry 1998 Jul;31(4):146-8. Department of Psychiatry, University of Heidelberg, Germany. Jauss@USA.net
Olanzapine is a newly developed atypical neuroleptic with a marked affinity to the 5-HT2, D2 and D4 dopamine receptors. Like other atypical neuroleptics olanzapine is considered to show a reduced prevalence of extrapyramidal side effects when compared to classical neuroleptic drugs.
We report on three patients with acute schizophrenia, who developed severe akathisia during treatment with olanzapine (20-25 mg/d). In two of these cases akathisia resolved after withdrawal of olanzapine and substitution by a classical or an atypical neuroleptic agent, respectively. In one of these patients olanzapine was well tolerated when reintroduced in combination with lorazepam after complete remission of akathisia.
In the third patient akathisia as sufficiently controlled by dose reduction. Akathisia is generally considered to result from D2 dopamine receptor antagonism. In the case of atypical neuroleptics such as olanzapine a low but still considerable D2 dopamine receptor occupancy may be compensated by the 5-HT2 antagonism. However, this mechanism may fail under certain circumstances, in particular if D2 dopamine antagonism exceeds a certain threshold. One should therefore be aware of possible extrapyramidal side effects with olanzapine that are reduced compared to classical neuroleptic drugs but not completely eliminated.
Molho ES, Factor SA (1999). Worsening of motor features of parkinsonism with olanzapine. Mov Disord 1999 Nov;14(6):1014-6. Department of Neurology, Albany Medical College, New York, USA.
Clozapine is the current treatment of choice for drug-induced psychosis (DIP) occurring in Parkinson's disease. However, alternative medications have been sought because of the small but significant risk of agranulocytosis and the need for frequent blood testing. The new "atypical" antipsychotic olanzapine (OLZ) has recently been proposed as a safe and effective option for treating psychosis in this setting. To investigate this, we retrospectively evaluated all 12 of our patients treated with OLZ for DIP. Symptoms of psychosis were improved in nine of 12 patients, but nine of 12 patients also experienced worsening of motor functioning while on OLZ. The worsening was considered dramatic in six of these patients. Overall, there was no significant increase in levodopa doses on OLZ. Only one patient remained on OLZ at the time of the analysis. Nine patients were switched to alternative treatment for DIP.
"We conclude that although Olanzapine may improve symptoms of psychosis in parkinsonian patients, it can also worsen motor functioning. In some patients, the degree of motor worsening may be intolerable." read the rest here

Nov 5, 2011

It's More Than Enough For Me

one day old

I am a single parent of two adult sons; my youngest son spent more than half of his childhood from the age of six until the age of seventeen in locked psychiatric wards; there are times to this day that the grief takes all of the wind from me, and I struggle to even stand upright.  I find myself holding my breath; because I'm afraid that if I breathe, I will start to cry, and once I cry----how will I ever stop?  There was and is so very much to grieve...The experiences themselves have not so much knocked me down; as they have beat any confidence I have in my fellow man out of me.  I am grateful beyond belief to have my son at all.  I voiced for the first time aloud at the beginning of April,  a precious truth for me: Every Day is Mother's Day.  I know I'm lucky my son has survived.  It is, I believe, a miracle and a blessing he is alive at all.

I cannot describe how humbled I have been by the last several months, nor can I describe to anyone how truly horrifying it has been to discover that the practice of psychiatry is as corrupt and unethical as it is.  The publicly funded mental health system, which includes the federally funded child welfare system, (CPS and foster care) violate the Constitutional Rights of the children and families it 'serves' as a matter of course.  I am more than horrified, I am disgusted.  At one time, I believed that my son's mistreatment by psychiatric and social services professionals who treated him as if he is "less than" human; and used him in drug trials was some kind of fluke, accident, travesty, or anomaly.  I now know it is common.  Knowing this makes it so much worse...

The primary purpose appears to be to expand the market for psychiatric drugs to ensure pharmaceutical industry profits.  Whether or not those "treated" are harmed by the psychiatric drugs, in real world practice, these negative outcomes of psychiatric patients is not a story that is told with accuracy; if told at all.  Only the biased story which supports the biological disease model is put forth.  I know it is the way things are done.  I am painfully aware that psychiatric drugs have caused my son grievous harm; have traumatized and disabled him.  I am at a loss to understand how the psychiatric profession has gotten away with this...


The drugs used are teratogenic.  Psychiatric drugs in all classes can cause iatrogenic illnesses and physiological dysfunction; decreasing the quality of life, and increasing risk of fatality---How was a profession built on fraud, corruption and outright lies about the safety and efficacy of it's "treatments" be given so much unearned trust and absolute power? Power to obtain Court Orders and to use the Police as agents who deliver their unwilling patients to locked facilities?  Civil Commitment investigators/petitioners are not required to conform to the Rules of Evidence when seeking to detain and involuntarily commit individuals they target; Standard Court Procedures are not followed; Effective Assistance of Counsel is not provided.  The Police, whose duty is to protect and to serve, become agents of psychiatry compelled by Court Order to deliver unwilling patients to locked facilities.

Antidepressants and neuroleptic drugs are two classes of psychiatric drugs that are now some of the most prescribed drugs.  These drugs are widely prescribed "off-label;" in spite of the overwhelming evidence that neither of these classes of drugs was therapeutic for the majority of people who took them in drug trials conducted to gain their FDA approval. Antidepressants and neurolelptics can cause dependence; and both have serious risks, including disability and early or sudden death.  Adults who take neuroleptic drugs long term, die an average of  25-30 years early; from drug induced illnesses; although the deaths are usually classified as natural.  Neuroleptics and antidepressants can cause debilitating illnesses, heart damage, brain damage, neurological impaiments, all obviously, horrifying traumatic iatrogenic injuries.

I was told by a psychiatrist in response to posting a psychiatric summary documenting the drugs and dosages given to my son in a two month period that, "No psychiatrist would see anything wrong" with how my son was 'treated;' he further stated that, "any parent who objected would at best be perceived as 'ill-informed' and at worst, as 'impaired' themselves."    In effect, using my boy as a guinea pig in drug trials while housing him in a disgusting and filthy environment for over $600. a day, and there's nothing wrong with it. I assure you, that the effects the drugs had were terrifying to him---I know when my son is terrified.  I saw his terror-filled look; I am haunted by the memory of it to this day.  I can still hear the echo of my son begging me to rescue him.   I remember being treated like I was crazy when I protested.  How dare I question the Quack Master Jack.


There was no questioning "Quack Master Jack's Authority."   While participating as an  investigator in the TEOSS drug trials, this "lead researcher" drugged my son into a state of profound disability.   Jon McClellan was one of the investigators funded by the  NIMH trialing neuroleptic drugs not approved for pediatric use.   Quack Master Jack needed no one's consent but his own--he had no one's consent but his own.


I remember thinking, "why does it look like my son is going die?"

I knew then, and I know now the 'treatment' has more in common with Science Fiction, than it does with medicine in the Hippocratic tradition.  The 'treatment' was ineffective, which is really no surprise.  Neuroleptic drugs have repeatedly been shown to be ineffective for the majority of people with symptoms of psychosis.  The neuroleptic drugs cause iatrogenic illnesses, disability and early death.  Nevertheless, psychiatry insists that these drugs are 'necessary medical treatment' and must be used by force for those who refuse. The drugs are what psychiatry uses; patient safety and drug efficacy do not matter; what matters is that one never question or doubt psychiatric authority.

The 'treatment' did nothing but cause my son physical illness, and further traumatize him. The drugs used in psychiatric "treatment" are known to be ineffective, the "treatment" is not based on Science--it is not Evidenced-Based Medicine; it is not supported by or derived from accurately reported clinical trial data.


In reality, psychiatric drug treatment protocols, like the psychiatric diagnoses themselves, are developed by consensus which is a pseudo-democratic political process. Psychiatrists vote diagnoses and treatment protocols into existence. Ultimately, the drugs used for a particular psychiatric diagnosis and the "Practice Parameters" psychiatry develops for each diagnosis are not derived from or supported by scientific data; but are based on subjective opinions voted on in a quasi-democratic political process know as consensus.  Why would psychiatry develop treatment protocols based on a consensus of subjective opinions and not the Clinical Trial data?  Psychiatry uses subjective opinions as a substitute for empirical data because the data does not support the use of psychiatric drugs.


Neuroleptic drugs have very serious, even fatal risks.  The drugs are "effective" for only a minority of people to whom they are prescribed.   Psychiatry ignores the Science, and the existing evidence-base and proclaims the drugs to be safe and effective; in spite of the scientific record not supporting this conclusion.  Students of psychiatry are taught a false history of psychiatry.  Students are not taught what is known, but what is believed, assumed or hoped to be true about the diagnoses themselves.   Students are not taught about what is known about the actual  effects of the drugs either.   The use of psychiatric drugs is not based on ethically conducted research with an unbiased reporting of the results.  As a result, psychiatric treatment using drugs is not scientifically valid, and is not therapeutic for many. Drugging of psychiatric symptoms is the only "medical treatment" that is carried out whether it's effects are therapeutic for an individual patient, or not.  Psychiatry claims to be a medical specialty, yet does not adhere to the scientific method and does not seem to even pay lip service to the Ethical Guidelines of the Medical profession.  Psychiatry ignores altogether the Nuremberg Code; with impunity.

I know that the statement that no psychiatrist would see anything wrong made by the psychiatrist in reference to my son's treatment is wrong.  l am grateful to know there are psychiatrists who do not "treat" humans in distress this way.  It is particularly disappointing this statement was made by a psychiatrist who apparently does not believe that a parent's duty and Constitutional Right to act on a child or adolescent's behalf should only be diminished or infringed upon to prevent abuse or neglect.


I know there are psychiatrists who would not agree with his statement, and would in fact see a whole lot wrong with how my son was treated.  Just because fraud and corruption are rampant and widespread in psychiatric research and practice, does not make the distortion of ethical medical  principles acceptable. Standard Practices used in psychiatry rely on consensus, seem to use consensus instead of data. Consensus is no substitute for factual data and information; and an opinion is not magically transformed into "evidence" because the opinion is shared by one's peers. Consensus is evidence of agreement; it is not evidence of medical validity.  
six years old
The lack of insight psychiatry has into the bind they put their patients in is truly frightening; to say the very least.  Psychiatry has convinced society that people with psychiatric diagnoses are not aware of reality and somehow, this erroneous belief justifies psychiatry treating them with dangerous and ineffective drugs as if they are not worthy of being treated with dignity or respect.  Our Nation's Institutions of Higher Learning doing psychiatric research have been funded by the pharmaceutical industry; psychiatry has somehow deluded it's practitioners into believing the people who are diagnosed with "mental illness" are incapable of recognizing when they are disrespected and invalidated.  Real concerns about the negative effects of psychiatric drugs from the patient or family members are attributed to sypmtoms of the diagnosis, are minimized, declared to be 'tolerable side effects,' or are ignored altogether.  


The attitude seems to be those who are labeled with a psychiatric diagnosis don't know what's 'good' for them; so what they experience, is not important.  How the treatment impacts the person, whether it is perceived as helpful or not; is considered to be unimportant. How can it be that a patient's perceptions and experiences are  not ever considered to be valid if the patient disagrees with the treating psychiatrist?  Nonetheless, a patient's perception is never as important as the patient's agreement to take the drugs exactly as prescribed; regardless of any actual benefit, or harm experienced.  The adverse effects and the potential for disability and death are not important; as long as compliance in taking drugs as prescribed is maintained.   How is it this is not recognized for what it is?  Using coercion and manipulation are an abuse of power and authority; the nature of these acts do not become 'therapeutic' because "it's for the patient's own good," and it is done under the guise of beneficence to provide "necessary medical treatment" Under Color of Law. 

My son is now a young man valiantly struggling to overcome the effects of outrageous abuse  and trauma his "medical treatment" has caused him; the 'treatment' amounted to repeated psychiatric assault and resulted in traumatic iatrogenic injuries from neuroleptic and other psychiatric drugs.  He is struggling to come to terms with the loss of cognitive and intellectual abilities.  He asked me in agony, "How could they take so much from me, Mom?"  There is no good or sufficient answer to this question; and the pain is, at times unbearable.  The damage caused to his spirit, is heartbreaking.  The damage done to his physical health and his continuing cognitive decline are in fact evidence of the criminal nature of his psychiatric treatment, and evidence of medical malpractice.  My son's "treatment" consisted of the law being repeatedly violated by the lead researcher in the State of Washington who was funded by the NIMH, and who works for the State of Washington as the Medical Director of the State's only psychiatric facility for children; and a professor of psychiatry at the University of Washington.  Not once have any of my complaints to the appropriate authorities in Washington State ever been investigated. 

I have no doubt that this is because it is the State of Washington that is ultimately liable. In my experience, the State of Washington protects the State of Washington; it does not act in defense of any victim unless forced to do so--even if the victim is a child or vulnerable adult.   The psychiatrist who did this to my son is still employed by the State of Washington, continues in his dual role as Medical Director of Child Study and Treatment Center and professor at University of Washington to this day.

People need to understand it is not an accurate or complete depiction in public service ads to "Bust the Stigma" of mental illness of how individuals given a psychiatric diagnosis experience life in the real world. More, people need to know it is not accurate to say the drugs are "safe and effective."  The anti-stigma efforts are not so much wrong, as they are biased, incomplete and inaccurate.  They neglect to even acknowledge there is a "potential" down side to getting a psychiatric diagnosis, and to treating symptoms associated with psychiatric diagnoses with psychiatric drugs.  The mainstream advocacy and anti-stigma activists fail to advocate for those with psychiatric diagnoses who are not served well by the psychopharmacology treatment paradigm, and/or those who have been harmed or otherwise victimized by unethical treatment providers in mental health service systems.  


Mainstream mental health advocates do not advocate for my son, or offer support to our family.  It is insulting to read in education and advocacy literature and hear in "public service" announcements that these advocates speak for all those with a psychiatric diagnosis and their families.   These advocates do not represent me, or my son.  The mental health professionals and social workers in the local public mental health system have no interest in helping my son in the slightest.  Psychiatry's victims are not acknowledged, they are effectively de-voiced, invalidated, and ignored.  Advocacy groups who claim to be speaking for everyone with a psychiatric diagnosis are not.  It is not possible to be advocating for the people with a psychiatric diagnosis while ignoring victims; psychiatric survivors who have recovered; parents who are taking care of disabled adult children; and parents who are grieving a child's early death from so-called "necessary medical treatment" with "safe and effective" drugs.  

The advocacy groups are funded and advised by the pharmaceutical industry and are intentionally not questioning  psychiatry's inexplicable devotion to the disease model.  These pharmaceutically-funded groups do not seem to question the alliances between the drug industry and the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry.  The obvious Conflicts of Interest have, in no small part, not only allowed but have perpetuated and even increased the harm done to real people; the devotion to the disease hypothesis and biological treatment paradigm have caused stigma to become deeply entrenched.  These advocacy groups do not advocate for victims, or for the grieving family members they leave behind.  The only people who are celebrated and advocated for are those who conform to the disease model, who are "treatment compliant."  This type of advocacy invalidates my son's lived experience; which was and is abusive.  My son's experiences were horrifying, and all too real.

What angers me the most is professionals and advocates who effectively deny the entirety of my son's history of trauma and subsequent psychiatric mistreatment.  My son has been consistently invalidated by virtually everyone who made decisions about how he would be treated and by whom.  I was also treated in this way, but my anger is for what was done to my son.


It is said that everything happens for a reason, and the only reason I can think of is so that I could see what I saw, and come to know what I know.  Some, if not most of the children who are Wards of the State do not have family involved at all and as such, are  children--who are left without protection.  Knowing these children do in fact exist, and are in need of protection, is what  motivates me more than anything else.  It is for these children in State Custody who are given no voice and no choice, that I share my family's story.   


I know the children who are in State Custody deserve better than to be given unsafe and ineffective drugs; I know that they should not be told that they have defective brains when their problems are caused by being neglected, abused and not having had basic needs consistently met.  These children deserve to be safe from unethical research, protected from being used as guinea pigs in Drug Trials, and "medically treated" using unethical "standard practices" which are not safe, effective or grounded in ethical research, or the ethical practice of medicine. The primary focus in medicine is to do what is in a patient's best interest, we fail far too often to maintain this focus when we allow children in foster care to be drugged instead of effectively helped.  Children must have their individual rights under the US Constitution preserved and defended---even if they are unaware of exactly what these rights are.  


I believe all of us have a duty to the children in State Custody.
Do you?

August 6, 2011
 post is inspired by two sentences of a commereader and was initially posted on April 8, 2011 titled, "It is More Than Enough" 

"It's enough to make anyone go insane.  Whs precisely what happens in those environments..."   Duane Sherry




In my own experience, it's more than enough to cause overwhelming grief...

LinkWithin

Related Posts Plugin for WordPress, Blogger...

FAIR USE NOTICE: This may contain copyrighted
(C) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available for educational purposes, to advance understanding of human rights, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in Title 17 U.S.C. section 107 of the US Copyright Law. This material is distributed without profit.